Search research articles
Contact Us
Filters
Showing results (11-20 of 212) with videos related to
Page
of 22
Sort By:
Nature Reviews. Cardiology
|
December 15, 2017
Role of titin in cardiomyopathy: from DNA variants to patient stratification
James S Ware, Stuart A Cook
The FEBS Journal
|
January 11, 2022
Therapeutic opportunities for senolysis in cardiovascular disease
Mark Sweeney, Stuart A Cook, Jesús Gil
Genome Medicine
|
February 24, 2017
Genetics and genomics of dilated cardiomyopathy and systolic heart failure
Upasana Tayal, Sanjay Prasad, Stuart A Cook
EMBO Molecular Medicine
|
September 21, 2020
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Mark Sweeney, Ben Corden, Stuart A Cook
Experimental & Molecular Medicine
|
December 2, 2020
Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway
Benjamin Ng, Stuart A Cook, Sebastian Schafer
Cardiovascular Research
|
January 19, 2010
MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism
Han Lu, Rachel J Buchan, Stuart A Cook
Journal of Molecular and Cellular Cardiology
|
December 17, 2008
Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure?
Stuart A Cook, Angela Clerk, Peter H Sugden
Nature Clinical Practice. Cardiovascular Medicine
|
November 3, 2005
Therapy insight: heart disease and the insulin-resistant patient
Stuart A Cook, Tim Aitman, Rossi P Naoumova
Cardiovascular Research
|
October 2, 2012
Integrative genomics in cardiovascular medicine
James S Ware, Enrico Petretto, Stuart A Cook
Heart (British Cardiac Society)
|
December 1, 2011
Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist
James S Ware, Angharad M Roberts, Stuart A Cook
Page
of 22
Search research articles
Search
Showing results (11-20 of 212) with videos related to
Sort By:
Page
of 22
Nature Reviews. Cardiology
|
December 15, 2017
Role of titin in cardiomyopathy: from DNA variants to patient stratification
James S Ware, Stuart A Cook
The FEBS Journal
|
January 11, 2022
Therapeutic opportunities for senolysis in cardiovascular disease
Mark Sweeney, Stuart A Cook, Jesús Gil
Genome Medicine
|
February 24, 2017
Genetics and genomics of dilated cardiomyopathy and systolic heart failure
Upasana Tayal, Sanjay Prasad, Stuart A Cook
EMBO Molecular Medicine
|
September 21, 2020
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Mark Sweeney, Ben Corden, Stuart A Cook
Experimental & Molecular Medicine
|
December 2, 2020
Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway
Benjamin Ng, Stuart A Cook, Sebastian Schafer
Cardiovascular Research
|
January 19, 2010
MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism
Han Lu, Rachel J Buchan, Stuart A Cook
Journal of Molecular and Cellular Cardiology
|
December 17, 2008
Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure?
Stuart A Cook, Angela Clerk, Peter H Sugden
Nature Clinical Practice. Cardiovascular Medicine
|
November 3, 2005
Therapy insight: heart disease and the insulin-resistant patient
Stuart A Cook, Tim Aitman, Rossi P Naoumova
Cardiovascular Research
|
October 2, 2012
Integrative genomics in cardiovascular medicine
James S Ware, Enrico Petretto, Stuart A Cook
Heart (British Cardiac Society)
|
December 1, 2011
Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist
James S Ware, Angharad M Roberts, Stuart A Cook
Page
of 22